Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

01-12-2012 | Commentary | Uitgave 1/2012 Open Access

Journal of Foot and Ankle Research 1/2012

Diabetes foot disease: the Cinderella of Australian diabetes management?

Tijdschrift:
Journal of Foot and Ankle Research > Uitgave 1/2012
Auteurs:
Peter A Lazzarini, Joel M Gurr, Joseph R Rogers, Andrew Schox, Shan M Bergin
Belangrijke opmerkingen

Competing interests

PAL and JMG were members of the Australian Diabetes Foot Network and along with SMB co-authored the Medical Journal of Australia article cited in this manuscript. PAL, JRR and AS are board members of the Australasian Podiatry Council and were involved in the drafting of the Australasian Podiatry Council Budget Submission cited in this manuscript. PAL was a member of the guidelines advisory committee that oversaw the development of the NHMRC diabetes foot guideline cited in this manuscript. The Australasian Podiatry Council co-funds the Journal of Foot and Ankle Research.

Authors’ contributions

PAL conceived, designed, searched literature, contributed to discussion, wrote and reviewed/edited the manuscript. JMG searched literature, contributed to discussion, wrote and reviewed/edited the manuscript. JRR, AS, SMB searched literature, contributed to discussion and reviewed/edited the manuscript. All authors read and approved the final manuscript.

Abstract

Diabetes is one of the greatest public health challenges to face Australia. It is already Australia’s leading cause of kidney failure, blindness (in those under 60 years) and lower limb amputation, and causes significant cardiovascular disease. Australia’s diabetes amputation rate is one of the worst in the developed world, and appears to have significantly increased in the last decade, whereas some other diabetes complication rates appear to have decreased. This paper aims to compare the national burden of disease for the four major diabetes-related complications and the availability of government funding to combat these complications, in order to determine where diabetes foot disease ranks in Australia. Our review of relevant national literature indicates foot disease ranks second overall in burden of disease and last in evidenced-based government funding to combat these diabetes complications. This suggests public funding to address foot disease in Australia is disproportionately low when compared to funding dedicated to other diabetes complications. There is ample evidence that appropriate government funding of evidence-based care improves all diabetes complication outcomes and reduces overall costs. Numerous diverse Australian peak bodies have now recommended similar diabetes foot evidence-based strategies that have reduced diabetes amputation rates and associated costs in other developed nations. It would seem intuitive that “it’s time” to fund these evidence-based strategies for diabetes foot disease in Australia as well.

Onze productaanbevelingen

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Literatuur
Over dit artikel

Andere artikelen Uitgave 1/2012

Journal of Foot and Ankle Research 1/2012 Naar de uitgave